Patent Assignment
Reel/Frame 023460/0093
Confirmatory License
Recorded: 2009-11-03
Pages: 2
Assignor
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTO
Executed: 2008-09-03
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Use of Adenosine Deaminase for Treating Pulmonary Disease
Application:
11/965,939 →
Publication:
US 2008/0159964
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 17, 2008
From: HORAK, IVAN; SAPRA, PUJA
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 020376/0314 →
Assignment of Assignor's Interest
Jan 17, 2008
From: BLACKBURN, MICHAEL R.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020378/0656 →
Assignment of Assignor's Interest
Apr 24, 2008
From: KELLEMS, RODNEY E.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020850/0268 →
Assignment of Assignor's Interest
Feb 16, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 023937/0530 →
Corrective Assignment to Correct the Applicant's Address Must Be Corrected in the Electronic Patent Assignment System Previously Recorded on Reel 023937 Frame 0533. Assignor(S) Hereby Confirms the Correct Address Is Rua Dos Ferreiros 260, Funchal-Madeira, Portugal, 9000-082.
Apr 26, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 024286/0076 →
Assignment of Assignor's Interest
Feb 7, 2012
From: DEFIANTE FARMACEUTICA, S.A.
To: SIGMA-TAU RARE DISEASES, S.A.
Reel/Frame 027662/0812 →